(Q30667144)

26 June 2017

1 reference

title

Dementia with Lewy bodies: diagnosis and management (English)

1 reference

dementia with Lewy bodies

26 June 2017

0 references

1 reference

Barber R

1

1 reference

26 June 2017

Panikkar A

series ordinal

2

1 reference

26 June 2017

McKeith IG

series ordinal

3

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

International Journal of Geriatric Psychiatry

26 June 2017

1 reference

26 June 2017

16 Suppl 1

1 reference

26 June 2017

S12-8

1 reference

Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease

26 June 2017

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Lewy bodies and response to tacrine in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Lewy-body dementia and responsiveness to cholinesterase inhibitors: a paradigm for heterogeneity of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Neuroleptic sensitivity to risperidone in Lewy body dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Do differences in visuospatial ability between senile dementias of the Alzheimer and Lewy body types reflect differences solely in mnemonic function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

Tacrine for senile dementia of Alzheimer's or Lewy body type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS562%3E3.0.CO%3B2-3

10.1002/1099-1166(200112)16:1+<::AID-GPS562>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference